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her systolic ankle artery pressures were reduced to 100 and 70
mm Hg on the right side and to 80 and 100 mm Hg on the left
side. The situational elevation of systemic blood pressure on the
initial presentation was not evident at serial follow-up measure-
ments. Concentric wall thickening in the common and superficial
femoral arteries with diffuse luminal narrowing was revealed 
by means of duplex ultrasound scanning. Stenoses higher than
50% were identified by means of duplex ultrasound scanning in
the left common femoral artery, at the ostium of both deep
Moyamoya disease, a rare cerebrovascular disorder of
unknown etiology, is characterized by bilateral stenosis or
occlusion of the internal carotid artery extending to the
proximal anterior and middle cerebral arteries and by a
prominent collateral network at the base of the brain.1,2
The age distribution of moyamoya disease shows a
bimodal pattern, with a first peak in childhood and a sec-
ond peak in the fourth decade of life.1 Although moy-
amoya disease is most prevalent in Japan, cases have been
reported worldwide and in patients of all ethnic back-
grounds.3
So far, the only extracranial vascular region known to
be affected in moyamoya disease has been the renal arter-
ies.4 We report the first case of typical moyamoya disease
in an adult woman that is associated with peripheral vas-
cular disease of the upper and lower extremities.
CASE REPORT
A 30-year-old white woman first came to our clinic in 1992
because of a 4-year history of bilateral calf-claudication after 300
to 400 m. She simultaneously complained about diffuse
headaches and subtle cognitive deficits, particularly affecting
long-term memory. The patient had no history of stroke, tran-
sient cerebral ischemia, syncope, or epilepsy. She had no cardio-
vascular risk factors, had a family history that was negative for
cardiovascular disease, and did not take any medication. The
results of a physical examination were normal, except for the
peripheral vascular system. Pulses of the upper limbs and femoral
arteries were normal, pulses of the popliteal arteries were dimin-
ished, and pulses of the dorsalis pedis arteries and posterior tibial
arteries were bilaterally absent. No bruits were audible at rest.
Her brachial blood pressure was 150/90 mm Hg bilaterally, and
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We report the case of a young white woman in whom cerebrovascular moyamoya disease, which was associated with
nonarteriosclerotic peripheral artery disease of the subclavian, iliac, and femoropopliteal arteries, was diagnosed by
means of angiography. During 8 years of follow-up, the peripheral artery disease progressed, without any signs char-
acteristic of systemic inflammation or vasculitis, leading to severe calf and arm claudication. Despite the absence of his-
tologic confirmation, this observation strongly suggests that peripheral artery involvement may be a feature of
moyamoya disease. To our knowledge, this is the first report of an association of classical cerebrovascular moyamoya
disease with peripheral artery disease. (J Vasc Surg 2001;34:943-6.)
Fig 1. Time-of-flight MRA of intracranial arteries showing cli-
noidal occlusion of internal carotid artery and of segments of cir-
cle of Willis and typical “puff of smoke” appearance of moyamoya
collateral vessels in brain stem.
femoral arteries, and in the proximal segment of both superficial
femoral arteries. Intrastenotic peak systolic flow velocities ranged
from 250 to 300 cm/s, with peak systolic flow velocity ratios
above 2.0, spectral broadening, and absence of reverse flow.
Plaques or calcification were not detected. Concentric wall thick-
ening in both common carotid arteries with an intimal-medial-
thickness between 1.2 and 1.4 mm was shown by means of a
duplex ultrasound scan analysis of the extracranial cerebral arter-
ies. Peak systolic flow velocity in both internal carotid arteries was
reduced to 20 cm/s with diastolic zero-flow, suggesting distal
occlusion. The results of laboratory tests were negative for car-
diovascular risk factors, systemic inflammation, and autoimmune
disease (Table). Bilateral, clinoidal occlusion of the internal
carotid arteries and of several portions of the circle of Willis was
confirmed by means of cranial magnetic resonance angiography
(MRA). Diffuse leptomeningeal enhancement and networks of
microcollaterals were detected along the brain stem and basal
ganglia (Fig 1). Normal muscle and vascular tissue without evi-
dence of inflammatory infiltration was shown by means of the
results of a deep muscle biopsy from the calf.
Because vasculitis could not be excluded, prednisolone ther-
apy was started at 60 mg per day and subsequently tapered. After
1 year with the patient showing no clinical improvement, pred-
nisolone was discontinued. During the next 8 years, the patient
experienced a further progression of the calf claudication and the
new onset of bilateral arm claudication. At a recent follow-up
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Fig 2. MRA after application of gadolinium diethylenetziamine penta-acetic acid of the right (A) and left (B) iliac and
femoral arteries showing diffuse luminal narrowing and smooth stenoses in right femoral bifurcation, left external iliac, and
left superficial femoral arteries.
A B
visit, bilaterally absent pulses of the brachial, radial, ulnar,
popliteal, dorsalis pedis, and posterior tibial arteries were revealed
by means of a vascular examination. Bruits were audible over both
subclavian, common femoral, and superficial femoral arteries. The
systolic brachial artery pressure measured by means of Doppler
ultrasound scanning was 70 mm Hg on the right side and 55 mm
Hg on the left side. Bilaterally, systolic ankle pressures had
declined to values between 70 and 85 mm Hg. Bilateral wall
thickening and luminal narrowing extending from the distal sub-
clavian arteries to the axillary and proximal brachial arteries were
revealed by means of a duplex ultrasound scanning analysis.
Diffuse narrowing of both iliac and femoral arteries and smooth,
concentric stenoses in the right femoral bifurcation and in the left
external iliac and superficial femoral arteries were shown by means
of MRA of the lower limbs (Fig 2).
DISCUSSION
The diagnosis of moyamoya disease is made on the
basis of characteristic findings in cerebral angiography1,2
that show bilateral stenosis or occlusion of the terminal
portion of the internal carotid artery, the proximal seg-
ments of the middle and anterior cerebral arteries, or both
and abnormal vascular networks at the base of the brain.2
Several studies have indicated that MRA is a suitable
means of detecting moyamoya disease.5 In our patient,
bilateral occlusion of the internal carotid artery and of the
proximal anterior and middle cerebral arteries and a
prominent collateral network in the brain stem were
clearly demonstrated by means of cerebral MRA, thus ful-
filling all diagnostic criteria for moyamoya disease.
The etiology of moyamoya disease is unknown.
Although most cases are sporadic, both genetic factors and
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environmental triggers are thought to play a role in the
etiology of the disease.6-8 The histopathologic correlate
typical of moyamoya disease consists of lipid-poor fibro-
cellular intimal thickening.9 These histologic changes are
not always restricted to the intracranial arteries, but have
also been detected in branches of the external carotid
artery.10 This observation suggests that moyamoya disease
may also affect extracranial arteries, thereby constituting a
systemic disorder. To date, the renal arteries have been the
only other vascular region known to be significantly
afflicted in moyamoya disease.4 However, we are not
aware of any report describing an involvement of
extrarenal peripheral arteries.
In our patient, concentric wall thickening with dif-
fuse luminal narrowing and smooth segmental stenoses
in several extracranial vascular regions, including the
common carotid, subclavian, axillary, brachial, superficial
femoral, deep femoral, and popliteal arteries, was
demonstrated by means of duplex ultrasound scanning
and MRA. The collateral pattern characteristic of cere-
bral moyamoya disease was not present in the peripheral
circulation. However, a differential response of distinct
vascular regions to the demands of chronic ischemia may
be conceivable. Although the morphology of the periph-
eral artery disease resembles the findings in giant cell or
Takayasu’s arteritis, we found no evidence for vasculitis
in the results of a deep muscle biopsy and documented
continuous progression of peripheral arteriopathy with-
out signs of systemic inflammation. We are aware that a
negative biopsy result and lack of systemic inflammation
do not eliminate the possibility of a large vessel vasculitis
Representative laboratory values during 8 years of follow-up
Reference
1992 1995 1998 2000 range
Hemoglobin (g/dL) 12.7 11.7 12.4 13.3 12.0-16.0
Hematocrit (%) 38 35 39 39 36-49
Leukocytes (103/µL) 8.9 8.0 8.9 7.6 4.0-10.0
Platelets (103/µL) 254 237 309 266 150-350
ESR (mm/h) 6/18 10/24 12/32 8/24 < 20/40
CRP (mg/L) < 5 < 5 < 5 < 5 < 5
Creatinine (µmol/L) 79 88 97 88 50-110
LDH (U/L) 160 163 158 164 80-240
Serum electrophoresis Normal Normal Normal Normal —
ANA Negative Negative Negative —
ANCA Negative Negative Negative —
ACA (U/mL) 6 6 0-12
Complement C3 (g/L) 1.07 1.26 0.8-1.9
Complement C4 (g/L) 0.24 0.28 0.2-0.5
Blood glucose (mmol/L) 4.7 4.6 6.7 4.7 3.9-6.1
Cholesterol (mg/dL) 134 142 137 < 200
Triglycerides (mg/dL) 46 97 83 < 200
LDL cholesterol (mg/dL) 81 88 76 < 160
HDL cholesterol (mg/dL) 44 35 44 > 35
Homocysteine (µmol/L) 7.5 5-15
Cryoglobulins (µg/mL) 10 0-80
ACA, Anticardiolipin antibodies; ANA, antinuclear antibodies; ANCA, anticytoplasmatic antibodies; CRP, C-reactive protein; ESR, erythrocyte sedimen-
tation rate; HDL, high-density lipoproteins; LDH, lactate dehydrogenase; LDL, low-density lipoproteins.
and that some uncertainty remains in the absence of a
histologic diagnosis. All the findings in our patient and
the clinical course of the disease strongly suggest, how-
ever, that both cerebrovascular moyamoya disease and
the peripheral arteriopathy are manifestations of a sys-
temic, noninflammatory vascular disorder. The apparent
dissociation in the kinetics of cerebral and peripheral
artery involvement may reflect different stages of the
same disease. Our patient’s end-stage cerebrovascular
involvement appeared to be burnt-out, whereas periph-
eral disease is still evolving.
Peripheral vascular involvement has not yet been
reported in Japan, where moyamoya disease occurs most
frequently. The clinical picture of moyamoya disease, how-
ever, may be different in Western populations than in
Japanese. One report from the United States3 suggests
that in white patients, moyamoya disease affects young
adults more frequently than children and that cerebral
hemorrhagic complications are less frequent. The later age
of onset and differences in the genetic and environmental
background in Western societies might explain a modified
course of moyamoya disease. The findings in our patient
suggest that in adult white patients, moyamoya disease
may present as a generalized vascular disorder simultane-
ously affecting the intracranial and the peripheral circula-
tion. As in our patient, claudication may be the leading
symptom of the disease.
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